0.023821 0.000000 0.000000 0.000000 0.023821 0.000000 0.000000 0.000000 0.011246 0.00000 0.00000 0.00000 Gamble, T.R. Yoo, S. Vajdos, F.F. Von Schwedler, U.K. Worthylake, D.K. Wang, H. Mccutcheon, J.P. Sundquist, W.I. Hill, C.P. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 8 90.00 90.00 90.00 41.980 41.980 88.920 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 Se 196.106 n SELENOMETHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Science SCIEAS 0038 0036-8075 278 849 853 10.1126/science.278.5339.849 9346481 Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. 1997 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 100 1 COLLIMATOR IMAGE PLATE 1996-12 MARRESEARCH SI(111) M x-ray 1 1.24 1.0 BL1-5 SSRL 1.24 SYNCHROTRON SSRL BEAMLINE BL1-5 8175.718 HIV CAPSID C-TERMINAL DOMAIN, RESIDUES 151 - 231 SELENOMETHIONINE SUBSTITUTIONS, L151MSE, M185MSE, M214MSE, M215MSE 1 man polymer 18.015 water 88 nat water no yes (MSE)DIRQGPKEPFRDYVDRFYKTLRAEQASQEVKNW(MSE)TETLLVQNANPDCKTILKALGPGATLEE(MSE) (MSE)TACQG MDIRQGPKEPFRDYVDRFYKTLRAEQASQEVKNWMTETLLVQNANPDCKTILKALGPGATLEEMMTACQG A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Lentivirus Escherichia Escherichia coli sample BL21 11676 Human immunodeficiency virus 1 469008 Escherichia coli BL21(DE3) BL21 (DE3) PET11A WISP97-7 1 2.21 43.8 VAPOR DIFFUSION, SITTING DROP 8.0 CRYSTALS OF CA(151-231) WERE GROWN AT 4C IN 4 MICROLITER SITTING DROPS CONTAINING A 1:1 MIXTURE OF PROTEIN SOLUTION (2.1 MM CA(151-231) IN 10MM TRIS (PH 8.0) AND 2 MM 2-MERCAPTOETHANOL) AND RESERVOIR SOLUTION (2.0 M AMMONIUM SULFATE), vapor diffusion - sitting drop, temperature 277K 277 repository Initial release Version format compliance Version format compliance 1 0 1998-10-14 1 1 2008-03-24 1 2 2011-07-13 1998-10-14 SPRSDE Y BNL 1998-03-27 REL REL HOH water HOH 1000 2 HOH HOH 1000 A HOH 1001 2 HOH HOH 1001 A HOH 1002 2 HOH HOH 1002 A HOH 1003 2 HOH HOH 1003 A HOH 1004 2 HOH HOH 1004 A HOH 1005 2 HOH HOH 1005 A HOH 1006 2 HOH HOH 1006 A HOH 1007 2 HOH HOH 1007 A HOH 1008 2 HOH HOH 1008 A HOH 1009 2 HOH HOH 1009 A HOH 1010 2 HOH HOH 1010 A HOH 1011 2 HOH HOH 1011 A HOH 1012 2 HOH HOH 1012 A HOH 1013 2 HOH HOH 1013 A HOH 1014 2 HOH HOH 1014 A HOH 1015 2 HOH HOH 1015 A HOH 1016 2 HOH HOH 1016 A HOH 1017 2 HOH HOH 1017 A HOH 1018 2 HOH HOH 1018 A HOH 1019 2 HOH HOH 1019 A HOH 1020 2 HOH HOH 1020 A HOH 1021 2 HOH HOH 1021 A HOH 1022 2 HOH HOH 1022 A HOH 1023 2 HOH HOH 1023 A HOH 1024 2 HOH HOH 1024 A HOH 1025 2 HOH HOH 1025 A HOH 1026 2 HOH HOH 1026 A HOH 1027 2 HOH HOH 1027 A HOH 1028 2 HOH HOH 1028 A HOH 1029 2 HOH HOH 1029 A HOH 1030 2 HOH HOH 1030 A HOH 1031 2 HOH HOH 1031 A HOH 1032 2 HOH HOH 1032 A HOH 1033 2 HOH HOH 1033 A HOH 1034 2 HOH HOH 1034 A HOH 1035 2 HOH HOH 1035 A HOH 1036 2 HOH HOH 1036 A HOH 1037 2 HOH HOH 1037 A HOH 1038 2 HOH HOH 1038 A HOH 1039 2 HOH HOH 1039 A HOH 1040 2 HOH HOH 1040 A HOH 1041 2 HOH HOH 1041 A HOH 1042 2 HOH HOH 1042 A HOH 1043 2 HOH HOH 1043 A HOH 1044 2 HOH HOH 1044 A HOH 1045 2 HOH HOH 1045 A HOH 1046 2 HOH HOH 1046 A HOH 1047 2 HOH HOH 1047 A HOH 1048 2 HOH HOH 1048 A HOH 1049 2 HOH HOH 1049 A HOH 1050 2 HOH HOH 1050 A HOH 1051 2 HOH HOH 1051 A HOH 1052 2 HOH HOH 1052 A HOH 1053 2 HOH HOH 1053 A HOH 1054 2 HOH HOH 1054 A HOH 1055 2 HOH HOH 1055 A HOH 1056 2 HOH HOH 1056 A HOH 1057 2 HOH HOH 1057 A HOH 1058 2 HOH HOH 1058 A HOH 1059 2 HOH HOH 1059 A HOH 1060 2 HOH HOH 1060 A HOH 1061 2 HOH HOH 1061 A HOH 1062 2 HOH HOH 1062 A HOH 1063 2 HOH HOH 1063 A HOH 1064 2 HOH HOH 1064 A HOH 1065 2 HOH HOH 1065 A HOH 1066 2 HOH HOH 1066 A HOH 1067 2 HOH HOH 1067 A HOH 1068 2 HOH HOH 1068 A HOH 1069 2 HOH HOH 1069 A HOH 1070 2 HOH HOH 1070 A HOH 1071 2 HOH HOH 1071 A HOH 1072 2 HOH HOH 1072 A HOH 1073 2 HOH HOH 1073 A HOH 1074 2 HOH HOH 1074 A HOH 1075 2 HOH HOH 1075 A HOH 1076 2 HOH HOH 1076 A HOH 1077 2 HOH HOH 1077 A HOH 1078 2 HOH HOH 1078 A HOH 1079 2 HOH HOH 1079 A HOH 1080 2 HOH HOH 1080 A HOH 1081 2 HOH HOH 1081 A HOH 1082 2 HOH HOH 1082 A HOH 1083 2 HOH HOH 1083 A HOH 1084 2 HOH HOH 1084 A HOH 1085 2 HOH HOH 1085 A HOH 1086 2 HOH HOH 1086 A HOH 1087 2 HOH HOH 1087 A MSE 151 n 1 MSE 151 A ASP 152 n 2 ASP 152 A ILE 153 n 3 ILE 153 A ARG 154 n 4 ARG 154 A GLN 155 n 5 GLN 155 A GLY 156 n 6 GLY 156 A PRO 157 n 7 PRO 157 A LYS 158 n 8 LYS 158 A GLU 159 n 9 GLU 159 A PRO 160 n 10 PRO 160 A PHE 161 n 11 PHE 161 A ARG 162 n 12 ARG 162 A ASP 163 n 13 ASP 163 A TYR 164 n 14 TYR 164 A VAL 165 n 15 VAL 165 A ASP 166 n 16 ASP 166 A ARG 167 n 17 ARG 167 A PHE 168 n 18 PHE 168 A TYR 169 n 19 TYR 169 A LYS 170 n 20 LYS 170 A THR 171 n 21 THR 171 A LEU 172 n 22 LEU 172 A ARG 173 n 23 ARG 173 A ALA 174 n 24 ALA 174 A GLU 175 n 25 GLU 175 A GLN 176 n 26 GLN 176 A ALA 177 n 27 ALA 177 A SER 178 n 28 SER 178 A GLN 179 n 29 GLN 179 A GLU 180 n 30 GLU 180 A VAL 181 n 31 VAL 181 A LYS 182 n 32 LYS 182 A ASN 183 n 33 ASN 183 A TRP 184 n 34 TRP 184 A MSE 185 n 35 MSE 185 A THR 186 n 36 THR 186 A GLU 187 n 37 GLU 187 A THR 188 n 38 THR 188 A LEU 189 n 39 LEU 189 A LEU 190 n 40 LEU 190 A VAL 191 n 41 VAL 191 A GLN 192 n 42 GLN 192 A ASN 193 n 43 ASN 193 A ALA 194 n 44 ALA 194 A ASN 195 n 45 ASN 195 A PRO 196 n 46 PRO 196 A ASP 197 n 47 ASP 197 A CYS 198 n 48 CYS 198 A LYS 199 n 49 LYS 199 A THR 200 n 50 THR 200 A ILE 201 n 51 ILE 201 A LEU 202 n 52 LEU 202 A LYS 203 n 53 LYS 203 A ALA 204 n 54 ALA 204 A LEU 205 n 55 LEU 205 A GLY 206 n 56 GLY 206 A PRO 207 n 57 PRO 207 A GLY 208 n 58 GLY 208 A ALA 209 n 59 ALA 209 A THR 210 n 60 THR 210 A LEU 211 n 61 LEU 211 A GLU 212 n 62 GLU 212 A GLU 213 n 63 GLU 213 A MSE 214 n 64 MSE 214 A MSE 215 n 65 MSE 215 A THR 216 n 66 THR 216 A ALA 217 n 67 ALA 217 A CYS 218 n 68 CYS 218 A GLN 219 n 69 GLN 219 A GLY 220 n 70 GLY 220 A author_defined_assembly 2 dimeric A MSE 151 SELENOMETHIONINE A MSE 1 MET A MSE 185 SELENOMETHIONINE A MSE 35 MET A MSE 214 SELENOMETHIONINE A MSE 64 MET A MSE 215 SELENOMETHIONINE A MSE 65 MET 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 8_665 -y+1,-x+1,-z+1/2 crystal symmetry operation 41.9800000000 41.9800000000 44.4600000000 1 A CD LYS 203 A CD LYS 53 0 Y 1 A CE LYS 203 A CE LYS 53 0 Y 1 A NZ LYS 203 A NZ LYS 53 0 Y 1 A THR 188 -100.08 -89.70 PARHCSDX.PRO TOPHCSDX.PRO TIP3P.PARAMETER TIP3P.TOPOLOGY 22.6 1.85 0.00 0.00 1.85 0.00 -3.69 BULK SOLVENT MODEL USED 0.253 0.008 0.215 0.215 1.70 25.00 969 9254 10.5 99.5 RANDOM 10000000.00 0.00100 1 RESTRAINED THROUGHOUT -2.0 MULTI-WAVELENGTH ANOMALOUS DISPERSION 0.23 0.21 5.00 0.19 0.19 1.70 25.00 88 644 0 0 556 0.005 1.1 20.4 1.01 1.31 1.50 2.12 2.00 2.41 2.00 3.92 2.50 0.328 0.027 0.276 1.81 153 1320 6 10.4 99.1 21.1 1.7 25.0 1A8O 9307 -2.0 0.036 1 15.0 99.6 1.7 1.73 5.0 0.232 98.6 data reduction DENZO data scaling SCALEPACK model building X-PLOR 3.843 refinement X-PLOR 3.843 phasing X-PLOR 3.843 HIV CAPSID HIV CAPSID C-TERMINAL DOMAIN 1 N N 2 N N A PHE 161 A PHE 11 HELX_P A GLU 175 A GLU 25 1 1 15 A GLN 179 A GLN 29 HELX_P A GLU 187 A GLU 37 1 2 9 A LEU 189 A LEU 39 HELX_P A GLN 192 A GLN 42 1 3 4 A PRO 196 A PRO 46 HELX_P A LEU 205 A LEU 55 1 4 10 A LEU 211 A LEU 61 HELX_P A ALA 217 A ALA 67 1 5 7 disulf 2.037 A CYS 198 A SG CYS 48 1_555 A CYS 218 A SG CYS 68 1_555 covale 1.326 A MSE 151 A C MSE 1 1_555 A ASP 152 A N ASP 2 1_555 covale 1.330 A MSE 185 A N MSE 35 1_555 A TRP 184 A C TRP 34 1_555 covale 1.333 A MSE 185 A C MSE 35 1_555 A THR 186 A N THR 36 1_555 covale 1.334 A MSE 214 A N MSE 64 1_555 A GLU 213 A C GLU 63 1_555 covale 1.332 A MSE 214 A C MSE 64 1_555 A MSE 215 A N MSE 65 1_555 covale 1.330 A MSE 215 A C MSE 65 1_555 A THR 216 A N THR 66 1_555 VIRAL PROTEIN CAPSID, CORE PROTEIN, HIV, C-TERMINAL DOMAIN, Viral protein POL_HV1N5 UNP 1 1 P12497 GARASVLSGGELDKWEKIRLRPGGKKQYKLKHIVWASRELERFAVNPGLLETSEGCRQILGQLQPSLQTGSEELRSLYNT IAVLYCVHQRIDVKDTKEALDKIEEEQNKSKKKAQQAAADTGNNSQVSQNYPIVQNLQGQMVHQAISPRTLNAWVKVVEE KAFSPEVIPMFSALSEGATPQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRLHPVHAGPIAPGQMREPRGSDIAGTTS TLQEQIGWMTHNPPIPVGEIYKRWIILGLNKIVRMYSPTSILDIRQGPKEPFRDYVDRFYKTLRAEQASQEVKNWMTETL LVQNANPDCKTILKALGPGATLEEMMTACQGVGGPGHKARVLAEAMSQVTNPATIMIQKGNFRNQRKTVKCFNCGKEGHI AKNCRAPRKKGCWKCGKEGHQMKDCTERQANFLGKIWPSHKGRPGNFLQSRPEPTAPPEESFRFGEETTTPSQKQEPIDK ELYPLASLRSLFGSDPSSQ 283 351 1A8O 152 220 P12497 A 1 2 70 96 P 43 21 2